{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:37:22Z","timestamp":1778125042748,"version":"3.51.4"},"reference-count":48,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP200100941"],"award-info":[{"award-number":["DP200100941"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Med Humanities"],"accepted":{"date-parts":[[2023,6,12]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Since the advent of more effective, new-generation treatment for hepatitis C, immense resources have been devoted to delivering cure to as many people with the virus as possible. The scale-up of treatment aims to prevent liver disease, liver cancer and onward transmission of hepatitis C, but social research shows that people also approach treatment with its social promises in mind, including the hope that it might reduce or eradicate stigma from their lives. Such hopes reflect broader ideas about medical cure, which is seen as an end point to illness and its effects, and capable of restoring the self to a (previous) state of health and well-being. But what does cure mean among people for whom treatment does not produce an end to the social effects of a heavily stigmatised disease? While new treatments promise to eliminate hepatitis C, accounts of post-cure life suggest that hepatitis C can linger in various ways. This article draws on interviews with people who have undergone treatment with direct-acting antivirals (n=30) in Australia to explore the meanings they attach to cure and their experiences of post-cure life. We argue that dominant biomedical understandings of cure as an \u2018ending\u2019 and a \u2018restoration\u2019 can foreclose insight into the social and other effects of illness that linger after medical cure, and how individuals grapple with those afterlives. Drawing on recent conceptual re-framings of cure from medical anthropology and disability studies, we suggest that thinking at the limits of \u2018curative reason\u2019 helps to better address the afterlives of chronic illness. In the case of hepatitis C, reconceptualising cure could inform improved and less stigmatising ways of addressing people\u2019s post-cure needs. And in the era of hepatitis C elimination, such reconceptualisation is increasingly important as the cohort of people undergoing treatment and cure expands worldwide.<\/jats:p>","DOI":"10.1136\/medhum-2023-012653","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T13:22:21Z","timestamp":1689340941000},"page":"678-687","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["\u2018I\u2019m not hep C free\u2019: afterlives of hepatitis C in the era of cure"],"prefix":"10.1136","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9490-4630","authenticated-orcid":false,"given":"Dion","family":"Kagan","sequence":"first","affiliation":[{"name":"Australian Research Centre for Sex, Health and Society, La Trobe University, Bundoora, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0886-7069","authenticated-orcid":false,"given":"Kate","family":"Seear","sequence":"additional","affiliation":[{"name":"Australian Research Centre for Sex, Health and Society, La Trobe University, Bundoora, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4465-2604","authenticated-orcid":false,"given":"Emily","family":"Lenton","sequence":"additional","affiliation":[{"name":"Australian Research Centre for Sex, Health and Society, La Trobe University, Bundoora, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3751-9060","authenticated-orcid":false,"given":"Adrian","family":"Farrugia","sequence":"additional","affiliation":[{"name":"Australian Research Centre for Sex, Health and Society, La Trobe University, Bundoora, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4785-484X","authenticated-orcid":false,"given":"kylie","family":"valentine","sequence":"additional","affiliation":[{"name":"Centre for Social Policy Research, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9200-054X","authenticated-orcid":false,"given":"Sean","family":"Mulcahy","sequence":"additional","affiliation":[{"name":"Australian Research Centre for Sex, Health and Society, La Trobe University, Bundoora, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"2025092412305289000_49.4.678.1","unstructured":"Anti-Discrimination Board of New South Wales . 2001. \u201cC-Change: Report of the Enquiry into Hepatitis C Related Discrimination.\u201d Sydney Anti-Discrimination Board of NSW. https:\/\/chodarr.org\/sites\/default\/files\/chodarr0403.pdf."},{"issue":"2","key":"2025092412305289000_49.4.678.2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3138\/canlivj.2019-0002","article-title":"\u201cHepatitis C Models of Care: Approaches to Elimination.\u201d","volume":"3","author":"Biondi","year":"2020","journal-title":"Canadian Liver Journal"},{"issue":"6","key":"2025092412305289000_49.4.678.3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/1753-6405.12809","article-title":"\u201cResponding to a National Policy Need: Development of a Stigma Indicator for Bloodborne Viruses and Sexually Transmissible Infections.\u201d","volume":"42","author":"Broady","year":"2018","journal-title":"Australian and New Zealand Journal of Public Health"},{"key":"2025092412305289000_49.4.678.4","unstructured":"Burnet Institute and Kirby Institute . 2020. \u201cAustralia\u2019s Progress Towards Hepatitis C Elimination: Annual Report 2020.\u201d Melbourne Burnet Institute. https:\/\/kirby.unsw.edu.au\/report\/australias-progress-towards-hepatitis-c-elimination-annual-report-2020."},{"key":"2025092412305289000_49.4.678.5","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9566.ep11339939"},{"key":"2025092412305289000_49.4.678.6","doi-asserted-by":"crossref","unstructured":"Clare E . 2017. Brilliant Imperfection: Grappling with Cure. Durham: Duke University Press. doi:10.1515\/9780822373520","DOI":"10.1515\/9780822373520"},{"key":"2025092412305289000_49.4.678.7","unstructured":"Department of Health . 2018. Fifth National Hepatitis C Strategy 2018-2022. Canberra: Australian."},{"issue":"2","key":"2025092412305289000_49.4.678.8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.18773\/austprescr.2021.003","article-title":"\u201cElimination of Hepatitis C in Australia by 2030: A Decade and Counting.\u201d","volume":"44","author":"Dore","year":"2021","journal-title":"Australian Prescriber"},{"key":"2025092412305289000_49.4.678.9","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-06829-2"},{"issue":"4\u20135","key":"2025092412305289000_49.4.678.10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/1467-9566.13467","article-title":"\u201cHepatitis C Cure as a \u2018Gathering\u2019: Attending to the Social and Material Relations of Hepatitis C Treatment.\u201d","volume":"44","author":"Farrugia","year":"2022","journal-title":"Sociology of Health & Illness"},{"key":"2025092412305289000_49.4.678.11","unstructured":"Farrugia A. , Fraser S. , Edwards M. , Madden A. , and Hocking S. . 2019. \u201cLived Experiences of Stigma and Discrimination Among People Accessing South Western Sydney Local Health District Drug Health Services.\u201d Melbourne The Australian Research Centre in Sex, Health and Society. https:\/\/www.latrobe.edu.au\/__data\/assets\/pdf_file\/0009\/1098126\/Lived-experiences-of-stigma-and-discrimination-among-people-accessing-SWSLHD-Drug-Health-Services.pdf."},{"key":"2025092412305289000_49.4.678.12","doi-asserted-by":"crossref","unstructured":"Fraser S. , Moore D. , Farrugia A. , Fomiatti R. , Edwards M. , Birbilis E. , and Treloar C. . 2022. \u201cExhausted Practical Sovereignty and Lateral Agency: Non-Uptake of Treatment for Hepatitis C in the Antiviral Era.\u201d The International Journal on Drug Policy 107. doi:10.1016\/j.drugpo.2022.103771","DOI":"10.1016\/j.drugpo.2022.103771"},{"key":"2025092412305289000_49.4.678.13","unstructured":"Fraser S. , and Seear K. . 2011. Making Disease, Making Citizens: The Politics of Hepatitis C. Aldershot: Ashgate."},{"key":"2025092412305289000_49.4.678.14","doi-asserted-by":"crossref","unstructured":"Goodyear T. , Brown H. , Browne A. J. , Hoong P. , Ti L. , and Knight R. . 2021. \u201c\u2018Stigma Is Where the Harm Comes from\u2019: Exploring Expectations and Lived Experiences of Hepatitis C Virus Post-Treatment Trajectories among People Who Inject Drugs.\u201d The International Journal on Drug Policy 96. doi:10.1016\/j.drugpo.2021.103238","DOI":"10.1016\/j.drugpo.2021.103238"},{"issue":"2","key":"2025092412305289000_49.4.678.15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/jvh.13020","article-title":"\u201cImproving Hepatitis C Direct-Acting Antiviral Access and Uptake: A Role for Patient-Reported Outcomes and Lived Experience.\u201d","volume":"26","author":"Goutzamanis","year":"2019","journal-title":"Journal of Viral Hepatitis"},{"key":"2025092412305289000_49.4.678.16","doi-asserted-by":"crossref","DOI":"10.4414\/SMW.2022.w30177","article-title":"\u201c\u2018Shaping the New Freedom\u2019: A Reflexive Thematic Analysis on Patients\u2019 Post Cure Needs after Years of Living with Hepatitis C.\u201d","volume":"152","author":"Guggisberg","year":"2022","journal-title":"Swiss Medical Weekly"},{"key":"2025092412305289000_49.4.678.17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.drugpo.2017.03.015","article-title":"\u201cManaging Expense and Expectation in a Treatment Revolution: Problematizing Prioritisation through an Exploration of Hepatitis C Treatment \u2018Benefit.\u2019\u201d","volume":"47","author":"Harris","year":"2017","journal-title":"The International Journal on Drug Policy"},{"key":"2025092412305289000_49.4.678.18","doi-asserted-by":"crossref","unstructured":"Harris M. , Guy D. , Picchio C. A. , White T. M. , Rhodes T. , and Lazarus J. V. . 2021. \u201cConceptualising Hepatitis C Stigma: A Thematic Synthesis of Qualitative Research.\u201d The International Journal on Drug Policy 96. doi:10.1016\/j.drugpo.2021.103320","DOI":"10.1016\/j.drugpo.2021.103320"},{"key":"2025092412305289000_49.4.678.19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugpo.2018.07.015","article-title":"\u201cCaring and Curing: Considering the Effects of Hepatitis C Pharmaceuticalisation in Relation to Non-Clinical Treatment Outcomes.\u201d","volume":"60","author":"Harris","year":"2018","journal-title":"The International Journal on Drug Policy"},{"key":"2025092412305289000_49.4.678.20","doi-asserted-by":"crossref","unstructured":"Kim E . 2017. Curative Violence: Rehabilitating Disability, Gender, and Sexuality in Modern Korea. Durham: Duke University Press.","DOI":"10.1515\/9780822373513"},{"issue":"10","key":"2025092412305289000_49.4.678.21","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep4.1246","article-title":"\u201cLiver Disease Monitoring Practices After Hepatitis C Cure in the Underserved Population.\u201d","volume":"2","author":"Kim","year":"2018","journal-title":"Hepatology Communications"},{"key":"2025092412305289000_49.4.678.22","unstructured":"Kirby Institute . 2018. \u201cHIV, Viral Hepatitis and Sexually Transmissible Infections in Australia: Annual Surveillance Report.\u201d Sydney Kirby Institute. https:\/\/kirby.unsw.edu.au\/report\/asr2018."},{"key":"2025092412305289000_49.4.678.23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1666841"},{"issue":"4","key":"2025092412305289000_49.4.678.24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1071\/PY20176","article-title":"\u201cUpscaling HIV and Hepatitis C Testing in Primary Healthcare Settings: Stigma-Sensitive Practice.\u201d","volume":"27","author":"Lenton","year":"2021","journal-title":"Australian Journal of Primary Health"},{"issue":"1","key":"2025092412305289000_49.4.678.25","first-page":"60","article-title":"\u201cEthical Issues in HealthConnect\u2019s Shared Electronic Health Record System.\u201d","volume":"12","author":"McSherry","year":"2004","journal-title":"Journal of Law and Medicine"},{"key":"2025092412305289000_49.4.678.26","doi-asserted-by":"crossref","unstructured":"Mol A . 1999. \u201cOntological Politics. A Word and Some Questions.\u201d The Sociological Review 47 (1)","DOI":"10.1111\/j.1467-954X.1999.tb03483.x"},{"issue":"2","key":"2025092412305289000_49.4.678.27","first-page":"93","article-title":"\u201cInsurance Discrimination and Hepatitis C: Recent Developments and the Need for Reforms.\u201d","volume":"32","author":"Mulcahy","year":"2022","journal-title":"Insurance Law Journal"},{"issue":"1","key":"2025092412305289000_49.4.678.28","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-018-0248-4","article-title":"\u201cBeyond Cure: Patient Reported Outcomes of Hepatitis C Treatment among People Who Inject Drugs in Australia.\u201d","volume":"15","author":"Madden","year":"2018","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"2025092412305289000_49.4.678.29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.18773\/austprescr.2018.005","article-title":"\u201cObservations on the Launch of New Drugs for Hepatitis C.\u201d","volume":"41","author":"Martinello","year":"2018","journal-title":"Australian Prescriber"},{"key":"2025092412305289000_49.4.678.30","doi-asserted-by":"crossref","unstructured":"Marshall A. D. , Rance J. , Grebely J. , and Treloar C. . 2022. \u201c\u2018Not Just One Box That You Tick off\u2019 - Deconstructing the Hepatitis C Care Cascade in the Interferon-Free Direct Acting Antiviral Era from the Client Perspective.\u201d The International Journal on Drug Policy 102. doi:10.1016\/j.drugpo.2022.103610","DOI":"10.1016\/j.drugpo.2022.103610"},{"key":"2025092412305289000_49.4.678.31","doi-asserted-by":"publisher","DOI":"10.1136\/medhum-2016-011099"},{"issue":"4","key":"2025092412305289000_49.4.678.32","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","article-title":"\u201cDecentralisation, Integration, and Task-Shifting in Hepatitis C Virus Infection Testing and Treatment: A Global Systematic Review and Meta-Analysis.\u201d","volume":"9","author":"Oru","year":"2021","journal-title":"The Lancet. Global Health"},{"issue":"1","key":"2025092412305289000_49.4.678.33","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-021-00494-4","article-title":"\u201cConsidering Treatment-as-Prevention Scale-up for Australian Prisons: A Qualitative Sub-Study of Expert Stakeholders from the Australian \u2018Surveillance and Treatment of Prisoners with Hepatitis C\u2019 Project (SToP-C).\u201d","volume":"18","author":"Rance","year":"2021","journal-title":"Harm Reduction Journal"},{"key":"2025092412305289000_49.4.678.34","doi-asserted-by":"crossref","unstructured":"Rhodes T. , and Lancaster K. . 2021. \u201cHow to Think with Models and Targets: Hepatitis C Elimination as a Numbering Performance.\u201d The International Journal on Drug Policy 88. doi:10.1016\/j.drugpo.2020.102694","DOI":"10.1016\/j.drugpo.2020.102694"},{"issue":"8","key":"2025092412305289000_49.4.678.35","doi-asserted-by":"crossref","DOI":"10.1186\/s41124-018-0036-5","article-title":"\u201cAchieving A Hepatitis C Cure: A Qualitative Exploration of the Experiences and Meanings of Achieving A Hepatitis C Cure Using the Direct Acting Antivirals in Australia.\u201d","volume":"3","author":"Richmond","year":"2018","journal-title":"Hepatology, Medicine and Policy"},{"key":"2025092412305289000_49.4.678.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.07.006"},{"key":"2025092412305289000_49.4.678.37","doi-asserted-by":"crossref","unstructured":"Seear K. , Fraser S. , Farrugia A. , and valentine k. . 2021. \u201cBeyond a \u2018Post-Cure\u2019 World: Sketches for a New Futurology of Hepatitis C.\u201d The International Journal on Drug Policy 94. doi:10.1016\/j.drugpo.2020.103042","DOI":"10.1016\/j.drugpo.2020.103042"},{"issue":"2","key":"2025092412305289000_49.4.678.38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/09646639221115698","article-title":"\u201cEchoes and Antibodies: Legal Veridiction and the Emergence of the Perpetual Hepatitis C Subject.\u201d","volume":"32","author":"Seear","year":"2022","journal-title":"Social & Legal Studies"},{"issue":"3","key":"2025092412305289000_49.4.678.39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/14461242.2021.1971102","article-title":"\u201cBecoming Posthuman: Hepatitis C, the Race to Elimination and the Politics of Remaking the Subject.\u201d","volume":"30","author":"Seear","year":"2021","journal-title":"Health Sociology Review"},{"issue":"1","key":"2025092412305289000_49.4.678.40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/1467-9566.13562","article-title":"\u201cComplicating Cure: How Australian Criminal Law Shapes Imagined Post-Hepatitis C Futures.\u201d","volume":"45","author":"Seear","year":"2022","journal-title":"Sociology of Health & Illness"},{"issue":"1","key":"2025092412305289000_49.4.678.41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/13557858.2015.1004870","article-title":"\u201cCare and Treatment of Hepatitis C among Aboriginal People in New South Wales, Australia: Implications for the Implementation of New Treatments.\u201d","volume":"21","author":"Treloar","year":"2016","journal-title":"Ethnicity & Health"},{"key":"2025092412305289000_49.4.678.42","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1093\/cid\/cit263","article-title":"\u201cUnderstanding Barriers to Hepatitis C Virus Care and Stigmatization from a Social Perspective.\u201d","volume":"57 Suppl 2","author":"Treloar","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"2025092412305289000_49.4.678.43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/medhum-2022-012382","article-title":"\u201cThe Freighted Social Histories of HIV and Hepatitis C: Exploring Service Providers\u2019 Perspectives on Stigma in the Current Epidemics.\u201d","volume":"49","author":"valentine","year":"2022","journal-title":"Medical Humanities"},{"issue":"2","key":"2025092412305289000_49.4.678.44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1215\/08992363-4310918","article-title":"\u201cOf Cures and Curses: Toward a Critique of Curative Reason.\u201d","volume":"30","author":"Venkat","year":"2018","journal-title":"Public Culture"},{"key":"2025092412305289000_49.4.678.45","unstructured":"Wendell S . 2016. \u201cUnhealthy Disabled: Treating Chronic Illnesses as Disabilities.\u201d In The Disability Studies Reader, edited by Davis L. J. , 5th ed, 161\u201377. New York: Routledge."},{"issue":"13\u201314","key":"2025092412305289000_49.4.678.46","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1111\/jocn.14083","article-title":"\u201cHepatitis C in a New Therapeutic Era: Recontextualising the Lived Experience.\u201d","volume":"27","author":"Whiteley","year":"2018","journal-title":"Journal of Clinical Nursing"},{"key":"2025092412305289000_49.4.678.47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.drugpo.2019.03.015","article-title":"\u201cLife Projects: The Transformative Potential of Direct-Acting Antiviral Treatment for Hepatitis C among People Who Inject Drugs.\u201d","volume":"72","author":"Williams","year":"2019","journal-title":"The International Journal on Drug Policy"},{"key":"2025092412305289000_49.4.678.48","unstructured":"World Health Organization (2016). Global Health Sector Strategy on Viral Hepatitis 2016\u20132021: Towards Ending Viral Hepatitis. Geneva: World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/246177"}],"container-title":["Medical Humanities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/medhum-2023-012653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:31:09Z","timestamp":1758742269000},"score":1,"resource":{"primary":{"URL":"https:\/\/mh.bmj.com\/lookup\/doi\/10.1136\/medhum-2023-012653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,12,19]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/medhum-2023-012653"],"URL":"https:\/\/doi.org\/10.1136\/medhum-2023-012653","relation":{},"ISSN":["1468-215X","1473-4265"],"issn-type":[{"value":"1468-215X","type":"print"},{"value":"1473-4265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]}}}